IL152154A0 - Sulfonamide-derivatives - Google Patents

Sulfonamide-derivatives

Info

Publication number
IL152154A0
IL152154A0 IL15215401A IL15215401A IL152154A0 IL 152154 A0 IL152154 A0 IL 152154A0 IL 15215401 A IL15215401 A IL 15215401A IL 15215401 A IL15215401 A IL 15215401A IL 152154 A0 IL152154 A0 IL 152154A0
Authority
IL
Israel
Prior art keywords
sulfonamide
derivatives
Prior art date
Application number
IL15215401A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL152154A0 publication Critical patent/IL152154A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/03Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C311/05Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL15215401A 2000-05-19 2001-05-04 Sulfonamide-derivatives IL152154A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20582200P 2000-05-19 2000-05-19
PCT/US2001/011746 WO2001090056A1 (en) 2000-05-19 2001-05-04 Sulfonamide derivatives

Publications (1)

Publication Number Publication Date
IL152154A0 true IL152154A0 (en) 2003-05-29

Family

ID=22763775

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15215401A IL152154A0 (en) 2000-05-19 2001-05-04 Sulfonamide-derivatives

Country Status (25)

Country Link
US (2) US6720357B2 (pl)
EP (1) EP1296944A1 (pl)
JP (1) JP2003534315A (pl)
KR (1) KR20030007643A (pl)
CN (1) CN1429206A (pl)
AR (1) AR028590A1 (pl)
AU (1) AU2001262936A1 (pl)
BR (1) BR0110871A (pl)
CA (1) CA2409829A1 (pl)
CZ (1) CZ20023796A3 (pl)
DZ (1) DZ3344A1 (pl)
EA (1) EA004868B1 (pl)
EC (1) ECSP014079A (pl)
HR (1) HRP20020917A2 (pl)
HU (1) HUP0302291A3 (pl)
IL (1) IL152154A0 (pl)
MX (1) MXPA02010021A (pl)
NO (1) NO20025533L (pl)
NZ (1) NZ521620A (pl)
PE (1) PE20011260A1 (pl)
PL (1) PL358184A1 (pl)
SK (1) SK16322002A3 (pl)
SV (1) SV2002000458A (pl)
WO (1) WO2001090056A1 (pl)
ZA (1) ZA200208746B (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA59384C2 (uk) * 1996-12-20 2003-09-15 Пфайзер, Інк. Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі
GB9702194D0 (en) 1997-02-04 1997-03-26 Lilly Co Eli Sulphonide derivatives
WO2003032974A2 (en) * 2001-10-12 2003-04-24 Eli Lilly And Company Use of sulfonamide derivatives as pharmaceuticals compounds
WO2005013961A1 (en) * 2003-07-17 2005-02-17 Eli Lilly And Company Combination therapy for treatment of cognitive disorders or psychoses
EP1663113A4 (en) * 2003-09-18 2007-06-13 Merck & Co Inc SUBSTITUTED SULFONAMIDE
BRPI1014583B1 (pt) 2009-06-26 2020-03-31 Pfizer, Inc. Sulfonamidas heterocíclicas e composições farmacêuticas
KR101569842B1 (ko) 2009-09-30 2015-11-17 삼성전자 주식회사 텔레비전용 전원공급유닛 및 이를 포함하는 텔레비전
WO2011109398A2 (en) 2010-03-02 2011-09-09 President And Fellows Of Harvard College Methods and compositions for treatment of angelman syndrome and autism spectrum disorders
US20150011554A1 (en) 2013-06-13 2015-01-08 Veroscience Llc Compositions and Methods for Treating Metabolic Disorders
EP3436021A4 (en) 2016-03-29 2019-11-06 RespireRx Pharmaceuticals Inc. COMPOSITIONS AND METHODS FOR TREATING ATTENTION DEFICIT DISORDER

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9702194D0 (en) * 1997-02-04 1997-03-26 Lilly Co Eli Sulphonide derivatives
PE20000943A1 (es) 1998-07-31 2000-09-28 Lilly Co Eli Derivados de sulfonamida
AU5235599A (en) * 1998-07-31 2000-02-21 Eli Lilly And Company N-substituted sulfonamide derivatives
ES2221410T3 (es) 1998-07-31 2004-12-16 Eli Lilly And Company Derivados heterociclil sulfamida.
PE20000942A1 (es) 1998-07-31 2000-09-28 Lilly Co Eli Derivados de amida, carbamato y urea

Also Published As

Publication number Publication date
EP1296944A1 (en) 2003-04-02
WO2001090056A1 (en) 2001-11-29
AR028590A1 (es) 2003-05-14
MXPA02010021A (es) 2003-02-12
US20040143020A1 (en) 2004-07-22
PE20011260A1 (es) 2001-12-11
ZA200208746B (en) 2004-02-10
US20030233015A1 (en) 2003-12-18
KR20030007643A (ko) 2003-01-23
PL358184A1 (pl) 2004-08-09
NO20025533D0 (no) 2002-11-18
US6803484B2 (en) 2004-10-12
JP2003534315A (ja) 2003-11-18
CA2409829A1 (en) 2001-11-29
NZ521620A (en) 2004-08-27
US6720357B2 (en) 2004-04-13
BR0110871A (pt) 2003-02-11
CZ20023796A3 (cs) 2003-04-16
ECSP014079A (es) 2002-02-25
EA200201232A1 (ru) 2003-04-24
AU2001262936A1 (en) 2001-12-03
HUP0302291A3 (en) 2006-11-28
DZ3344A1 (fr) 2001-11-29
HRP20020917A2 (en) 2004-02-29
EA004868B1 (ru) 2004-08-26
SK16322002A3 (sk) 2003-05-02
NO20025533L (no) 2003-01-20
HUP0302291A2 (hu) 2003-11-28
CN1429206A (zh) 2003-07-09
SV2002000458A (es) 2002-10-24

Similar Documents

Publication Publication Date Title
DE60105852D1 (en) Fluidmischsystem
DE50112082D1 (en) Bulk-acoustic-wave-filter
DE60121590D1 (en) Pyrazolderivate
DE60115644D1 (en) Thiazinoxazolidinon
DE50104081D1 (en) Hydrolager
AU3391801A (en) Pyridinylimidazoles
DE60128102D1 (en) Imidazolderivate
AU8274301A (en) Electro-powder
DE50105205D1 (en) Creatinin-biosensor
DE60114954D1 (en) Polytrimethylenterephthalatgarn
AU6803901A (en) Bis-arylsulfones
DE50112740D1 (en) Strangführungselement
DE50110569D1 (en) Substituierte c-cyclohexylmethylamin-derivate
DE50107376D1 (en) Orientierte acrylathotmelts
DE60120222D1 (en) Laser-anemometer
DE50102859D1 (en) Hochfliessfähige propylenblockcopolymerisate
DE50107703D1 (en) Creatininsensor-kalibration
DE50112014D1 (en) Stiftheizer
AU9385201A (en) Sulfonylguanidine
AU6619001A (en) Liquid-pourers
DE50008626D1 (en) Substituierte aminomethyl-phenyl-cyclohexanderivate
DE50114303D1 (en) Nsaugluftkanal
IL152154A0 (en) Sulfonamide-derivatives
DE60114837D1 (en) Signalmessung
DE50008447D1 (en) Aminomethyl-phenyl-cyclohexanonderivate